Synthesis and Biological Evaluation of Imadazo[1,2-a]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus

por Alsfouk, Aisha A., Alshibl, Hanan M., Alsfouk, Bshra A., Altwaijry, Najla A., Al-Abdullah, Ebtehal S.
Publicado 2022

New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches

por Alsfouk, Aisha A., Alshibl, Hanan M., Altwaijry, Najla A., Alanazi, Ashwag, AlKamaly, Omkulthom, Sultan, Ahlam, Alsfouk, Bshra A.
Publicado 2023

The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway

por Gupta, Kartikey Kumar, Sharma, Kamal Kant, Chandra, Harish, Panwar, Himalaya, Bhardwaj, Nitin, Altwaijry, Najla A., Alsfouk, Aisha A., Dlamini, Zodwa, Afzal, Obaid, Altamimi, Abdulmalik S. A., Khan, Shahanavaj, Mishra, Abhay Prakash
Publicado 2022

Evaluation of the Potential of National Sharing of a Unified Progress Test Among Colleges of Pharmacy in the Kingdom of Saudi Arabia

por Albekairy, Abdulkareem M, Obaidat, Aiman A, Alsharidah, Mansour S, Alqasomi, Abdulmajeed A, Alsayari, Abdulrhman S, Albarraq, Ahmad A, Aljabri, Ahmad M, Alrasheedy, Alian A, Alsuwayt, Bader H, Aldhubiab, Bandar E, Almaliki, Faisal A, Alrobaian, Majed M, Aref, Mohammad A, Altwaijry, Najla A, Alotaibi, Nasser H, Alkahtani, Saad A, Bahashwan, Saleh A, Alahmadi, Yaser A
Publicado 2021